(NEW YORK)Shares of Sangamo BioSciences Inc. jumped Wednesday after the developer of genetic-based therapies said it signed a licensing deal with pharmaceuticals giant Roche.READ MORE
Among the stock activity stories for Wednesday, July 9, from AP Financial News: NEW YORK (AP)--Shares of Cleveland-Cliffs Inc. soared on Wednesday after the iron and coal miner rai...READ MORE
(RICHMOND, Calif.)Sangamo BioSciences Inc., which develops genetic-based therapies, said Monday data shows the company's technology can make certain cells in the immune system resistant to the H...READ MORE
(NEW YORK)Dow AgroSciences' move to license genetic-based therapies from Sangamo Biosciences Inc. could mean a large infusion of cash with little loss of product rights for the biotechno...READ MORE
(SAN DIEGO)Sangamo BioSciences Inc., which develops genetic-based therapies, said Thursday Dow AgroSciences exercised an option to license technology from Sangamo that turns genes on or off.READ MORE
(NEW YORK)Shares of Sangamo BioSciences Inc. plunged Friday after the company said it will double the size of a midstage study and increase dosing for its nerve-disorder drug candidate, rais...READ MORE